Sort
39,280 grants matching “leukemia”
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
$511,864Uttiya Basu · Columbia University Health Sciences · R01 · FY2021 · AI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy
$511,811Weiqiang Chen · New York University · R01 · FY2022 · CA
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
$511,800Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2024 · CA
FANCONI ANEMIA GENE FUNCTION IN GENOME STABILITY AND TUMOR SUPPRESSION
$511,770Robb E Moses · Oregon Health & Science University · P01 · FY2007 · HL
Genetic Dissection of Drosophila Hematopoiesis
$511,756Utpal Banerjee · University Of California Los Angeles · R01 · FY2006 · HL
Predictive Markers in Metastatic Renal Cancer
$511,714Eric J Small · University Of California, San Francisco · R01 · FY2012 · CA
The cohesin complex as a tumor suppressor in myeloid leukemia
$511,640Iannis Aifantis · New York University School Of Medicine · R01 · FY2018 · CA
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
$511,614Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Cell migration and cell-cell interactions in bone marrow
$511,606Ulrich H Von Andrian · Immune Disease Institute, Inc. · P01 · FY2009 · HL
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
$511,603Tait D Shanafelt · Mayo Clinic Rochester · R01 · FY2016 · CA
Functional Genomic Study of Aging and Aging Interventions
$511,594Sige Zou · National Institute On Aging · ZIA · FY2011 · AG
The Role of Canonical and Non-canonical Autophagy in B Cell Immunity
$511,515Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2018 · AI
Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing
$511,434Bingliang Fang · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Towards rational design of combination therapeutic targets
$511,423Kai Tan · Children'S Hosp Of Philadelphia · U01 · FY2020 · CA
Effect of Tobacco Advocacy at the State Level
$511,397Stanton Arnold Glantz · University Of California, San Francisco · R01 · FY2017 · DA
Carrier Mediated Antifolate Transport and Resistance
$511,375Israel David Goldman · Albert Einstein College Of Medicine · R01 · FY2008 · CA
CD19 Directed CAR Therapy
$511,366Carl H. June · University Of Pennsylvania · R01 · FY2012 · CA
Targeted Therapies for Lymphoid Malignancies
$511,329Jennifer A. Woyach · Ohio State University · R01 · FY2024 · CA
SUMO modification and cancer therapy
$511,259Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2015 · GM
Radiolabeled Antibody Therapy of Acute Leukemia
$511,196Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
Targeting the Ig-light chains with CAR-T cells in lymphoid tumors
$511,190Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
Cancer and Leukemia Group B
$511,085Harold J. Burstein · Dana-Farber Cancer Inst · U10 · FY2010 · CA
Validation of prognostic and pathway signatures in lethal prostate cancer
$511,043Susan Halabi · Duke University · U01 · FY2013 · CA
Mechanism and therapeutic opportunities of targeting the Tudor domain
$510,917Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
MLL FUSION GENES IN MYELOID AND LYMPHOID LEUKEMIAS
$510,801Scott A Armstrong · Dana-Farber Cancer Inst · P01 · FY2008 · CA